Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

R&D Market Pulse: No Brexit Deal Could Upset UK’s R&D

By R&D Editors | October 22, 2018

The R&D Index for the week ending October 19, 2018 closed at 4,465.39 for the 25 companies in the R&D Index. The Index was down -0.89% (or -40.17 basis points) from the week ending October 12, 2018. The stock of thirteen R&D Index companies gained value last week from 0.06% (Volkswagen AG) to 6.68% (GlaxoSmithKline). The stock of twelve R&D Index companies lost value last week from -0.15% (Honda) to -8.34% (IBM).

R&D Index member IBM fell to its lowest stock value in a year following announcement that it failed to reach its long-held goal of getting more than 50% of its revenue from cloud computing, data analytics and other fast-growing IT businesses. 3Q 2018 revenue fell 2.1% from 3Q 2017 revenue, overall profit fell 1.2% to $2.69 billion for the quarter.

A recent survey of 2,000 business leaders in France, Germany, Spain and the UK by Washington, DC-based FTI Consulting revealed that more than 60% of UK businesses are preparing to move their R&D facilities out of the UK following the departure of the UK from the European Union (Brexit), which is now scheduled for March 29, 2019. A recent conference hosted by Texas-based market research firm Frost & Sullivan concluded that the UK and the EU will reach a trade deal before the Brexit deadline, despite their failure to reach a deal in early October. The FTI report reveals that the survey respondents are preparing for a ‘no-deal’ scenario with contingency planning that could have a major impact on the UK economy.

In related Brexit news, Cancer Research UK recently announced that they are collaborating with two peer organizations in Italy and Spain to fund several new R&D projects—providing an example that Brexit is not a hindrance to UK-EU R&D cooperation. One of the sticking points right now is how to avoid the re-emergence of physical border in Ireland.

The Labor Department announced last Tuesday that the number of available jobs in the U.S. out-numbered the number of jobless people actively looking for work by more than 900,000, the highest such statistic on record.

Minutes released by the Fed last week of its latest meeting (September 26), revealed a consensus of policy makers that their current schedule of interest rate increases (three so far in 2018 with one more likely in December and three scheduled for 2019) are likely to be maintained due to continued strength in the job market and overall economy.

      R&D Index Week Ending October 19, 2018      
    Ticker Exchange 2018 R&D millions U.S. $ 10/12/18 10/19/18 10/19/18 to 10/12/18 10/19/18 to 12/29/17
1 Amazon AMZN NASDAQ 26,750 1,788.61 1,764.03 -1.37% 50.84%
2 Alphabet/Google GOOGL NASDAQ 18,796 1,120.54 1,105.18 -1.37% 4.92%
3 Apple AAPL NASDAQ 14,037 222.11 219.31 -1.26% 29.59%
4 Intel INTC NASDAQ 13,702 44.88 44.00 -1.98% -4.68%
5 Microsoft MSFT NASDAQ 13,558 109.57 108.66 -0.83% 27.03%
6 Roche Pharm RHHBY OTC 12,284 29.70 30.60 3.03% -3.10%
7 Johnson & Johnson JNJ NYSE 11,493 133.87 139.05 3.87% -0.48%
8 Merck & Co. MRK NYSE 11,323 69.81 72.35 3.64% 28.58%
9 Volkswagen AG VWAGY OTC 10,915 15.95 15.96 0.06% -60.53%
10 Toyota TM NYSE 10,848 116.76 116.32 -0.38% -8.53%
11 Novartis NVS NYSE 8,934 82.78 87.19 5.33% 3.85%
12 Honda HMC NYSE 8,180 27.21 27.17 -0.15% -20.28%
13 Pfizer PFE NYSE 7,942 43.78 44.50 1.64% 22.86%
14 Daimler DDAIY OTC 7,615 61.47 59.13 -3.81% -30.07%
15 General Motors GM NYSE 7,278 31.79 31.20 -1.86% -23.88%
16 Oracle ORCL NYSE 7,001 47.38 47.59 0.44% 0.66%
17 Bristol-Myers Squibb BMY NYSE 6,981 57.51 54.30 -5.58% -11.39%
18 Eli Lilly Co LLY NYSE 6,769 110.48 111.92 1.30% 32.51%
19 GlaxoSmithKline GSK NYSE 6,394 38.31 40.87 6.68% 15.22%
20 Cisco CSCO NASDAQ 6,009 45.71 45.34 -0.81% 18.38%
21 IBM IBM NYSE 5,842 140.85 129.10 -8.34% -15.85%
22 Bayer AG BAYN OTC 5,743 22.16 22.48 1.44% -27.69%
23 Astra Zeneca PLC AZN NYSE 5,483 37.15 39.21 5.55% 13.00%
24 Qualcomm QCOM NASDAQ 5,183 64.29 65.36 1.66% 2.09%
25 Sanofi SA SNY NYSE 4,694 42.89 44.57 3.92% 3.65%
  Total     243,754 4,505.56 4,465.39 -0.89% 17.76%
                 
      Biopharmaceutical 668.44 687.04 2.78% 7.73%
      Automotive 253.18 249.78 -1.34% -23.67%
      ICT   1,795.33 1,764.54 -1.72% 6.47%

About the R&D Index

R&D Magazine’s R&D Index is a weekly stock market summary of the top international companies involved in research and development. The top 25 industrial spenders of R&D in 2017 were selected based on the latest listings from Schonfeld & Associates’ June 2018 R&D Ratios & Budgets. These 25 companies include pharmaceutical (11 companies), automotive (5), ICT (8) and conglomerate (1) organizations who invested a cumulative total of more than $209 billion in R&D in 2017, or approximately 10% of all the R&D spent in the world by government, industries and academia combined, according to R&D Magazine’s 2018 Global R&D Funding Forecast. The stock prices used in the R&D Index are tabulated from NASDAQ, NYSE, XETRA and OTC common stock prices (in U.S. dollars) for the companies selected at the close of stock trading business on the Friday preceding the publication of the R&D Index in R&D Magazine’s R&D Daily eNewsletter.

The companies used in the R&D Index include Amazon, Alphabet/Google, Microsoft, Intel, Apple, Volkswagen AG, Roche Pharma, Toyota, Johnson & Johnson, Novartis, General Motors, Pfizer, Bristol-Myers Squibb, Cisco, Qualcomm, Oracle, Honda Motor Company, Astra Zeneca plc, Merck & Company, Daimler, Bayer AG, Sanofi SA, IBM, GlaxoSmithKline and Eli Lilly Co. Stock prices are based on those stocks traded on the U.S. exchanges. R&D Index trends (in the stock prices) are just one indicator of the amount of capital available to these high-technology companies to invest in R&D and should not be implied to indicate the absolute value of R&D investments made by these organizations. The companies chosen for the R&D Index have very large sophisticated internal and global R&D organizations with each company investing between $4.5 and $17 billion annually on their R&D efforts.

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
7 major R&D developments this week: Tariff uncertainty persists, Pfizer sells campus, Scania acquires Northvolt unit
economic crisis stock chart falling down business global money bankruptcy concept
7 major R&D developments this week: Tariffs roil markets, MIT wins $12B contract, Siemens plans $5B acquisition
EL SEGUNDO, CA/USA - OCTOBER 13, 2014: Boeing manufactuing facility. Boeing manufactures and sells aircraft, rotorcraft, rockets and satellites. It is the second-largest defense contractor in the world.
8 major R&D moves this week: HHS cuts 10,000 jobs while Anthropic & DataBricks form $100M pact
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE